Crossmark

ANXA2 in hepatocellular carcinoma: orchestrating tumorigenesis, progression, and therapeutic resistance toward precision targeting

Published Online: 2025-10-15

Authors

Chen, Junyu

Li, Jianlin

Ran, Liuxin

Yang, Jianbo

Xie, Yang https://orcid.org/0000-0003-4293-0014
Funding

Funding for this research was provided by:

Affiliated Hospital of Southwest Medical University (2024LCYXZX53)

Southwest Medical University (202510632061)
License Information

Text and Data Mining valid from 2025-10-15

Version of Record valid from 2025-10-15
More Information

Article History

Received: 21 May 2025

Accepted: 12 September 2025

First Online: 15 October 2025

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current